Starkville doctor convicted of receiving and distributing wrongly branded drugs | USAO-NDMS
Oxford, Mississippi. – A Starkville doctor was sentenced today to three years’ probation for receiving ill-branded drugs in interstate commerce and distributing them with the intent to defraud his patients. In addition to the probation period, the defendant was ordered to confiscate $ 105,322.53, pay a fine of $ 95,000 and pay restitution of $ 377,545.20.
According to court documents, Benjamin Franklin Sanford, Jr., 69, of Starkville, Mississippi, is a doctor who operated on internal medicine in Starkville. From April 2013 to June 2018, foreign versions of prescription drugs, including versions of Prolia, Boniva, and Aclasta, which had not been approved by the FDA, were shipped from overseas to Dr. Sanford in Starkville. These drugs were administered to Starkville Internal Medicine patients without their knowledge that the drugs were foreign versions of the drugs in question that were not approved by the FDA.
“American consumers rely on FDA oversight to make sure the drugs they receive are safe and effective. Healthcare providers who obtain unapproved foreign drugs and then dispense and administer them to their patients are putting the health of those patients at risk, ”said Special Agent in Charge Justin C. Fielder, Bureau of Criminal Investigations of the FDA in Miami. “We will continue to prosecute and bring to justice those who choose to endanger public health.”
“For medical care, patients rely on safe and approved medications from their doctors,” said Derrick L. Jackson, special agent in charge at the US Department of Health and Human Services, Office of the Inspector General in Atlanta. . “This conviction and financial penalties will deter other medical providers from looking for imported drugs not approved by the FDA.”
The FDA’s Bureau of Criminal Investigations and the US Department of Health and Human Services, Office of the Inspector General, investigated the case. The case was continued by AUSA Robert Mims.